Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 437

1.

Characterization of CD4 T Cell Epitopes of Infliximab and Rituximab Identified from Healthy Donors.

Hamze M, Meunier S, Karle A, Gdoura A, Goudet A, Szely N, Pallardy M, Carbonnel F, Spindeldreher S, Mariette X, Miceli-Richard C, Maillère B.

Front Immunol. 2017 May 5;8:500. doi: 10.3389/fimmu.2017.00500. eCollection 2017.

2.

International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus.

Kleinmann JF, Tubach F, Le Guern V, Mathian A, Richez C, Saadoun D, Sacre K, Sellam J, Seror R, Amoura Z, Andres E, Audia S, Bader-Meunier B, Blaison G, Bonnotte B, Cacoub P, Caillard S, Chiche L, Chosidow O, Costedoat-Chalumeau N, Daien C, Daugas E, Derdèche N, Doria A, Fain O, Fakhouri F, Farge D, Gabay C, Guillo S, Hachulla E, Hajjaj-Hassouni N, Hamidou M, Houssiau FA, Jourde-Chiche N, Koné-Paut I, Ladjouz-Rezig A, Lambotte O, Lipsker D, Mariette X, Martin-Silva N, Martin T, Maurier F, Meckenstock R, Mékinian A, Meyer O, Mohamed S, Morel J, Moulin B, Mulleman D, Papo T, Poindron V, Puéchal X, Punzi L, Quartier P, Sailler L, Smail A, Soubrier M, Sparsa A, Tazi-Mezalek Z, Zakraoui L, Zuily S, Sibilia J, Gottenberg JE.

Autoimmun Rev. 2017 Jun;16(6):650-657. doi: 10.1016/j.autrev.2017.04.011. Epub 2017 Apr 18. Review.

PMID:
28434948
3.

Takayasu Arteritis and Spondyloarthritis: Coincidence or Association? A Study of 14 Cases.

Rivière E, Arnaud L, Ebbo M, Allanore Y, Claudepierre P, Dernis E, Ziza JM, Miceli-Richard C, Philippe P, Richez C, Soubrier M, Belkhir R, Seror R, Mariette X, Pavy S; on behalf of the Club Rhumatismes et Inflammations..

J Rheumatol. 2017 Apr 15. pii: jrheum.160762. doi: 10.3899/jrheum.160762. [Epub ahead of print]

PMID:
28412700
4.

Cost-Effectiveness of TNF-Blocker Injection Spacing for Patients with Established Rheumatoid Arthritis in Remission: An Economic Evaluation from the Spacing of TNF-Blocker Injections in Rheumatoid Arthritis Trial.

Vanier A, Mariette X, Tubach F, Fautrel B; STRASS Study Group..

Value Health. 2017 Apr;20(4):577-585. doi: 10.1016/j.jval.2017.01.005. Epub 2017 Mar 10.

PMID:
28407999
5.

Vaccination recommendations for the adult immunosuppressed patient: A systematic review and comprehensive field synopsis.

Lopez A, Mariette X, Bachelez H, Belot A, Bonnotte B, Hachulla E, Lahfa M, Lortholary O, Loulergue P, Paul S, Roblin X, Sibilia J, Blum M, Danese S, Bonovas S, Peyrin-Biroulet L.

J Autoimmun. 2017 Jun;80:10-27. doi: 10.1016/j.jaut.2017.03.011. Epub 2017 Apr 2. Review.

PMID:
28381345
6.

A new MHC-linked susceptibility locus for primary Sjögren's syndrome: MICA.

Carapito R, Gottenberg JE, Kotova I, Untrau M, Michel S, Naegely L, Aouadi I, Kwemou M, Paul N, Pichot A, Locke J, Bowman SJ, Griffiths B, Sivils KL, Sibilia J, Inoko H, Micelli-Richard C, Nocturne G, Ota M, Ng WF, Mariette X, Bahram S.

Hum Mol Genet. 2017 Apr 4. doi: 10.1093/hmg/ddx135. [Epub ahead of print]

PMID:
28379387
7.

A multi-parameter response prediction model for rituximab in rheumatoid arthritis.

de Jong TD, Sellam J, Agca R, Vosslamber S, Witte BI, Tsang-A-Sjoe M, Mantel E, Bijlsma JW, Voskuyl AE, Nurmohamed MT, Verweij CL, Mariette X.

Joint Bone Spine. 2017 Mar 28. pii: S1297-319X(17)30054-4. doi: 10.1016/j.jbspin.2017.02.015. [Epub ahead of print]

PMID:
28363827
8.

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.

Smolen JS, Landewé R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, Nam J, Ramiro S, Voshaar M, van Vollenhoven R, Aletaha D, Aringer M, Boers M, Buckley CD, Buttgereit F, Bykerk V, Cardiel M, Combe B, Cutolo M, van Eijk-Hustings Y, Emery P, Finckh A, Gabay C, Gomez-Reino J, Gossec L, Gottenberg JE, Hazes JMW, Huizinga T, Jani M, Karateev D, Kouloumas M, Kvien T, Li Z, Mariette X, McInnes I, Mysler E, Nash P, Pavelka K, Poór G, Richez C, van Riel P, Rubbert-Roth A, Saag K, da Silva J, Stamm T, Takeuchi T, Westhovens R, de Wit M, van der Heijde D.

Ann Rheum Dis. 2017 Jun;76(6):960-977. doi: 10.1136/annrheumdis-2016-210715. Epub 2017 Mar 6.

PMID:
28264816
9.

Reply.

Vitali C, Scofield H, Shiboski SC, Criswell LA, Lietman TM, Seror R, Labetoulle M, Mariette X, Rasmussen A, Bowman SJ, Shiboski CH.

Arthritis Rheumatol. 2017 Mar 3. doi: 10.1002/art.40085. [Epub ahead of print] No abstract available.

PMID:
28257605
10.

Baseline autoantibodies preferentially impact abatacept efficacy in patients with rheumatoid arthritis who are biologic naïve: 6-month results from a real-world, international, prospective study.

Alten R, Nüßlein HG, Mariette X, Galeazzi M, Lorenz HM, Cantagrel A, Chartier M, Poncet C, Rauch C, Le Bars M.

RMD Open. 2017 Feb 13;3(1):e000345. doi: 10.1136/rmdopen-2016-000345. eCollection 2017.

11.

Onset of connective tissue disease following anti-PD1/PD-L1 cancer immunotherapy.

Le Burel S, Champiat S, Routier E, Aspeslagh S, Albiges L, Szwebel TA, Michot JM, Chretien P, Mariette X, Voisin AL, Lambotte O.

Ann Rheum Dis. 2017 Feb 27. pii: annrheumdis-2016-210820. doi: 10.1136/annrheumdis-2016-210820. [Epub ahead of print] No abstract available.

PMID:
28242618
12.

Analysis of non-melanoma skin cancer across the tofacitinib rheumatoid arthritis clinical programme.

Curtis JR, Lee EB, Martin G, Mariette X, Terry KK, Chen Y, Geier J, Andrews J, Kaur M, Fan H, Nduaka CI.

Clin Exp Rheumatol. 2017 Feb 27. [Epub ahead of print]

13.

Prevalence of primary Sjögren Syndrome: What if Sjögren was right after all?

Nocturne G, Seror R, Devauchelle-Pensec V, Saraux A, Mariette X, Chiche L.

Arthritis Care Res (Hoboken). 2017 Feb 19. doi: 10.1002/acr.23223. [Epub ahead of print] No abstract available.

PMID:
28217861
14.

Impact of anti-TNF therapy on NK cells function and on immunosurveillance against B-cell lymphomas.

Nocturne G, Boudaoud S, Ly B, Pascaud J, Paoletti A, Mariette X.

J Autoimmun. 2017 Jun;80:56-64. doi: 10.1016/j.jaut.2017.02.001. Epub 2017 Feb 14.

PMID:
28214146
15.

Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials.

Cohen SB, Tanaka Y, Mariette X, Curtis JR, Lee EB, Nash P, Winthrop KL, Charles-Schoeman C, Thirunavukkarasu K, DeMasi R, Geier J, Kwok K, Wang L, Riese R, Wollenhaupt J.

Ann Rheum Dis. 2017 Jan 31. pii: annrheumdis-2016-210457. doi: 10.1136/annrheumdis-2016-210457. [Epub ahead of print]

16.

Cost-effectiveness of rituximab strategies in rheumatoid arthritis.

Seror R, Mariette X.

Lancet. 2017 Jan 28;389(10067):365-366. doi: 10.1016/S0140-6736(17)30053-3. No abstract available.

PMID:
28137690
17.

Erratum to: Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis.

Sellam J, Rivière E, Courties A, Rouzaire PO, Tolusso B, Vital EM, Emery P, Ferracioli G, Soubrier M, Ly B, Chavez HH, Taoufik Y, Dougados M, Mariette X.

Arthritis Res Ther. 2017 Jan 23;19(1):11. doi: 10.1186/s13075-017-1221-4. No abstract available.

18.

Safety of surgery in patients with rheumatoid arthritis treated by abatacept: data from the French Orencia in Rheumatoid Arthritis Registry.

Latourte A, Gottenberg JE, Luxembourger C, Pane I, Claudepierre P, Richette P, Lafforgue P, Combe B, Cantagrel A, Sibilia J, Flipo RM, Gaudin P, Vittecoq O, Schaeverbeke T, Dougados M, Sellam J, Ravaud P, Mariette X, Seror R.

Rheumatology (Oxford). 2017 Apr 1;56(4):629-637. doi: 10.1093/rheumatology/kew476.

PMID:
28053274
19.

The effect of body mass index on clinical response to abatacept as a first-line biologic for rheumatoid arthritis: 6-month results from the 2-year, observational, prospective ACTION study.

Mariette X, Alten R, Nüßlein HG, Galeazzi M, Lorenz HM, Cantagrel A, Chartier M, Poncet C, Rauch C, Le Bars M.

Joint Bone Spine. 2016 Dec 30. pii: S1297-319X(16)30210-X. doi: 10.1016/j.jbspin.2016.10.011. [Epub ahead of print]

PMID:
28043761
20.

Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the "pan-European registry collaboration for abatacept (PANABA).

Iannone F, Courvoisier DS, Gottenberg JE, Hernandez MV, Lie E, Canhão H, Pavelka K, Hetland ML, Turesson C, Mariette X, Choquette D, Finckh A.

Clin Rheumatol. 2017 Apr;36(4):773-779. doi: 10.1007/s10067-016-3505-5. Epub 2016 Dec 14.

PMID:
27966068

Supplemental Content

Loading ...
Support Center